Scilex Holding (SCLX) Revenue Growth (3y) (2025 - 2026)

Scilex Holding (SCLX) Revenue Growth (3y) (2025 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue Growth (3y) (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	5.56%
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	7.01%
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	3.37%
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	8.00%
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	10.45%
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	12.90%
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	5.75%
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	62.71%
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	7.90%
10	Scilex Holding	39.22 Mn	-73.57 Mn	3.97 Mn	-15.31%

Download Data